Scandinavian Medical Solutions A/S (CPH:SMSMED)
3.070
+0.010 (0.33%)
Jul 28, 2026, 4:48 PM CET
Scandinavian Medical Solutions Earnings Call Transcripts
Fiscal Year 2025
-
Revenue and EBITDA guidance were significantly lowered due to geopolitical risks, tariff uncertainty, and a weaker US dollar. Order book visibility has shortened, but strong US presence and cost controls provide strategic flexibility. Demand for used equipment remains robust, especially in private US healthcare.
Fiscal Year 2024
-
Revenue and EBITDA met guidance, with strong H2 margin recovery after one-time investments. Rental fleet achieved 100% utilization, aided by the Pay-Per-Scan model, and the U.S. subsidiary contributed early sales and rentals. Guidance for next year targets further growth and profitability.